PROCEPT BioRobotics Corporation revised revenue guidance for the full year 2023. For the year, the company expects revenue for the full year 2023 to be approximately $133.5 million, which represents 78% growth over the Company?s prior year revenue. This compares to previous revenue guidance of $131.0 million.
PROCEPT BioRobotics Corporation
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.48 USD | -3.62% | -6.14% | +53.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.85% | 3.44B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.10% | 40.74B | |
+19.92% | 31.6B | |
+15.66% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- PRCT Stock
- News PROCEPT BioRobotics Corporation
- PROCEPT BioRobotics Corporation Revises Revenue Guidance for the Full Year 2023